Jack H Jhamandas Selected Research

Islet Amyloid Polypeptide Receptors

10/2021	Genetic Depletion of Amylin/Calcitonin Receptors Improves Memory and Learning in Transgenic Alzheimer's Disease Mouse Models.
1/2017	Amylin Receptor: A Potential Therapeutic Target for Alzheimer's Disease.
6/2013	Role of amylin and its receptors in neurodegeneration.
1/2013	Amylin receptor: a common pathophysiological target in Alzheimer's disease and diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack H Jhamandas Research Topics

Disease

22	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 02/2002
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 10/2007
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 02/2013 - 08/2010
2	Amyloid Plaque 01/2017 - 11/2003
2	Gliosis 12/2014 - 09/2010
2	Essential Hypertension 07/2014 - 01/2011
2	Wounds and Injuries (Trauma) 07/2014 - 01/2011
2	Myocardial Infarction 07/2014 - 01/2011
2	Pain (Aches) 01/2011 - 01/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Insulin Resistance 01/2020
1	Cognitive Dysfunction 01/2017
1	Diabetes Mellitus 01/2013
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 09/2012
1	Parkinson Disease (Parkinson's Disease) 09/2012
1	Type 2 Diabetes Mellitus (MODY) 05/2012
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2011
1	Coinfection 09/2010
1	HIV Infections (HIV Infection) 09/2010
1	Infections 09/2010
1	Polyneuropathies (Polyneuropathy) 07/2008
1	Neuroinflammatory Diseases 10/2007
1	Disease Progression 10/2007
1	Hypovolemia 05/2006
1	Hypertrophy 02/2006
1	Hyperalgesia 01/2006
1	Chronic Pain 01/2006
1	Dehydration (Water Stress) 04/2003
1	Hypotension (Low Blood Pressure) 06/2002

Drug/Important Bio-Agent (IBA)

11	Peptides (Polypeptides)IBA 10/2021 - 11/2003
11	Amyloid (Amyloid Fibrils)IBA 10/2021 - 10/2007
9	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2004
5	Amyloid beta-PeptidesIBA 01/2012 - 11/2003
4	Islet Amyloid Polypeptide ReceptorsIBA 10/2021 - 01/2013
4	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 01/2011 - 06/2002
3	Islet Amyloid PolypeptideIBA 10/2021 - 06/2003
3	Amino Acids FDA Link 01/2012 - 05/2005
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2021 - 10/2007
2	Amyloidogenic ProteinsIBA 12/2014 - 05/2012
2	Prion ProteinsIBA 02/2013 - 08/2010
2	Staphylococcal Protein A (Protein A)IBA 01/2012 - 08/2007
2	Vasopressins (Vasopressin)IBA 01/2011 - 05/2006
2	GalaninIBA 02/2006 - 02/2002
1	Calcitonin Receptors (Calcitonin Receptor)IBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Hormones (Hormone)IBA 01/2020
1	KetonesIBA 01/2020
1	PrionsIBA 09/2012
1	tau Proteins (tau Protein)IBA 09/2012
1	Protein Isoforms (Isoforms)IBA 09/2012
1	SynucleinsIBA 09/2012
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2011
1	vpr Gene ProductsIBA 09/2010
1	Proteinase-Activated ReceptorsIBA 10/2007
1	Peptide Hydrolases (Proteases)FDA Link 10/2007
1	Interleukin-4 (Interleukin 4)IBA 10/2007
1	amyloid beta-protein (1-42)IBA 10/2007
1	Glial Fibrillary Acidic ProteinIBA 10/2007
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2007
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2007
1	NeuropeptidesIBA 02/2006
1	Heroin (Diamorphine)IBA 01/2006
1	Opioid Analgesics (Opioids)IBA 01/2006
1	neuropeptide FF receptorIBA 01/2006
1	LipopolysaccharidesIBA 04/2003
1	Cholinergic Agents (Cholinergics)IBA 02/2002

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2011
1	Denervation 07/2008